Daniel Winter Goodman
Fondatore presso Psychogenics, Inc.
Posizioni attive di Daniel Winter Goodman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Direttore/Membro del Consiglio | 01/01/2000 | - |
| Fondatore | 01/01/1998 | - | |
| Amministratore Delegato | 01/01/1998 | 01/01/2000 | |
| Riverside Pharmaceuticals Corp. | Amministratore Delegato | 01/01/2012 | - |
| Fondatore | 01/01/2012 | - | |
| Weill Cornell Medical College | Corporate Officer/Principal | - | - |
| The Midtown Practice For Psychotherapy & Psychiatry | Fondatore | 01/01/2017 | - |
| Presidente | 01/01/2017 | - | |
| Daniel Goodman MD PC | Fondatore | 01/01/2003 | - |
| Presidente | 01/01/2003 | - |
Storia della carriera di Daniel Winter Goodman
Precedenti posizioni note di Daniel Winter Goodman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Direttore/Membro del Consiglio | 06/05/2019 | 06/05/2022 |
| Independent Dir/Board Member | 06/05/2019 | 06/05/2022 | |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Fondatore | 20/06/2001 | - |
| Presidente | 20/06/2001 | - |
Formazione di Daniel Winter Goodman
| Harvard Medical School | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
| Yale College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
Posizioni
| Founder | 5 |
| President | 3 |
| Director/Board Member | 2 |
Settori
| Consumer Services | 5 |
| Health Technology | 4 |
| Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| Aziende private | 5 |
|---|---|
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
| Riverside Pharmaceuticals Corp. | Miscellaneous |
| The Midtown Practice For Psychotherapy & Psychiatry | |
| Daniel Goodman MD PC |
